Immediate Impact

1 by Nobel laureates 53 standout
Sub-graph 1 of 20

Citing Papers

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Diagnosis and Management of Pituitary Adenomas
2023 Standout
2 intermediate papers

Works of Daniela Gaia being referenced

Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours
2006
Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancy
1997

Author Peers

Author Last Decade Papers Cites
Daniela Gaia 380 140 35 120 11 435
María A. Gálvez 343 126 47 92 16 405
Pedro Benito-López 257 110 39 65 15 398
Ariel Barkan 390 150 37 172 22 475
Laurie A. Kane 241 83 40 207 9 429
Christine Cortet 382 71 48 157 17 485
P. Uitterlinden 331 62 18 129 11 406
M Scanarini 350 168 86 96 14 497
Peter Groth 329 113 37 112 18 470
B. Delemer 221 112 26 81 18 393
Akira Sata 243 69 32 68 18 382

All Works

Loading papers...

Rankless by CCL
2026